Prilosec OTC Switchback: Plans Should Look To OTCs For Savings, Study Says
This article was originally published in The Tan Sheet
Executive Summary
Health plan administrators should consider coverage of OTCs to reduce pharmacy benefit costs, authors of an Arkansas study on the cost impact of covering Prilosec OTC (omeprazole magnesium) say
You may also be interested in...
Prilosec OTC “Coverage Gap” Pitch Spotlights Medicare Payment Question
An initiative promoting Prilosec OTC over prescription competitors to help Medicare Part D users avoid "the coverage gap" in their prescription costs may prompt a closer look at ways Medicare can pay for OTCs
Prilosec OTC “Coverage Gap” Pitch Spotlights Medicare Payment Question
An initiative promoting Prilosec OTC over prescription competitors to help Medicare Part D users avoid "the coverage gap" in their prescription costs may prompt a closer look at ways Medicare can pay for OTCs
Prilosec OTC “Coverage Gap” Pitch Spotlights Medicare Payment Question
An initiative promoting Prilosec OTC over prescription competitors to help Medicare Part D users avoid "the coverage gap" in their prescription costs may prompt a closer look at ways Medicare can pay for OTCs